Hims & Hers Health Inc. Class A (NYSE:HIMS)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
HIMS Weekly Chart

Old Forum Content for HIMS

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • scottrades: ...
    $HIMS Watch for an upside reversal

    Let’s go to work,

    Scott

  • bill52: @scottrades $GDX $MSTR $AEM $AMZN $EBAY $SE $SPOT $ROAD $HIMS Scott, outstanding write up this morning. Its definitely easy to have a quick trigger finger to sell out of a position too soon given the recent turmoil back in April. Tests one's nerves for sure.
  • wijimmy: $HIMS ..@SCOTT .. nice call quick 3% ..THX…closing in on HOD
  • scottrades: $HIMS upside reversal working
  • scottrades: @wijimmy $HIMS Nice!!
  • scottrades: My notes: $SPY Weak close $QQQ Weak close $IWM Holding the 21 EMA $TNA Bounce just above the 50 Day $GLD Channel $SLV Back testing the 50 $GDX Top of the channel $IBIT To the moon $SNOW Holding the breakout $MSTR Watch 430 $COIN Higher High $ZS Tight base. Earnings next week $CRWD Nice ase, earnings coming up. $CTAS Short base $NDAQ Short Channel $RL Watch 283.70 $HIMS support at the 21 EMA $WPM Watch Yesterdays high $AEM Needs a break out of the channel $KGC Watch 14.75
  • woodman: $HIMS - I bought some today at 56 and change on this pullback to the 8dEMA. Stop under low of the day.
  • dgrobo: The H twins competing for star pupil $HIMS $HOOD
  • wijimmy: $HIMS …. Crushing it …….moving up with volume due to price target upgrades.
  • dgrobo: $TTD taking a little breather today. Notice volume last few days. $HIMS big volume also last couple of weeks. Whales buying apparently
  • champ: $HIMS ...up another 15% today.
  • dgrobo: $HIMS winning
  • joelsg1: @woodman $LLY $MCK $CAH $NVO $NOV Interesting that now the GLP-1 stocks have reversed and moved higher. Maybe they know this executive order lacks teeth, or that they'll make it back with volume, $AMGN, $LLY and $HIMS.
  • Cashmere: $HIMS up on volume
  • dgrobo: @Cashmere $HIMS very strong horse.
  • dgrobo: $HIMS continues higher post earnings. Strong volume
  • haroldzero: @dgrobo $HIMS Glad I am in this trade. :)
  • champ: $HIMS....nice, might continue...
  • dgrobo: $HIMS down pre-market, but still above break-out level from news on 4/29. Little below $39 at the moment. AI summary from earnings. https://www.perplexity.ai/search/please-summarize-earnings-and-MYTdhfKnTXmWH4avXTs6xw
  • dgrobo: $HIMS up at open
  • DAN: @dgrobo $HIMS In light of their business, it's not surprising that the stock is "up." ;-)
  • dgrobo: @DAN $HIMS for men of a certain age?
  • dgrobo: $HIMS still going
  • traderbren: @dgrobo $HIMS - yep, Hims is squeezing Hers...or is it the other way round! ;)
  • champ: $HIMS....HOD, up 18% and it sure looks like it is going to keep growing legs. This is turning out to be a real nice ride, I added this morning. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~
  • haroldzero: @champ $HIMS I am in. Thanks Champ
  • champ: @haroldzero $HIMS .....Nice, but watch closely... because stocks that have nice moves like this, could maybe fall back... when all the #CopyCat-sellers start to take their profits off......the herd might be triggered, to move off at some point.....so for safety, for saving profits, could have bracketed-trailing stops in place. Your broker will help you Set-them-up, if needed. Good Luck!
  • StockMarketMentor: ...
    This is a big week for earnings, with $MSTR, $PLTR, $ON and $HIMS reporting today. ($MSTR should be explosive)

    Tomorrow we hear from $AMD and $SMCI, both of which sport charts that suck.

    Wednesday morning we’ll hear $UBER, and from $DIS ...
  • Nepenthe: @StockMarketMentor $MSTR $PLTR $ON $HIMS $AMD $SMCI $UBER $DIS $SHOP $COIN $NET Weren't $MSTR's earnings last Thursday? They did seem rather muted, so maybe I have it wrong. Cheers.
  • efrain007: @StockMarketMentor $MSTR $PLTR $ON $HIMS $AMD $SMCI $UBER $DIS $SHOP $COIN $NET Looks like $MSTR reported last week but correct me if I'm wrong because I own $MSTU and wouldn't want to hold through earnings.
  • cgendro1: @Nepenthe $MSTR $PLTR $ON $HIMS $AMD $SMCI $UBER $DIS $SHOP $COIN $NET - $MSTR reported on 5/1 per my findings. Next report Aug 7 per Zacks
  • ManSim: @StockMarketMentor $MSTR $PLTR $ON $HIMS $AMD $SMCI $UBER $DIS $SHOP $COIN $NET " Hi Dan, would you please discuss how Buffett's retirement could impact $BRK.A $BRK.B in both the short and long term in today’s section? Would you also comment on the view that many investors hold BRK.A/B largely out of admiration for Buffett himself? Is this a valid argument, and are there any historical precedents where a revered leader’s departure significantly impacted investor sentiment or stock performance? Thank you.
  • champ: $HIMS ...looking positive and they will be reporting their earnings after the close today, I might swing a small position..?? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
  • dgrobo: $HIMS nice looking chart imo
  • champ: $HIMS is HOD, up over 11%.
  • Vineet: @jpoko13 $HMIS #Pre-earnings my guess $HIMS
  • bwcarnation1: @jpoko13 $HMIS #Pre-earnings I think he meant $HIMS
  • champ: @jpoko13 $HMIS #Pre-earnings ....Sorry it is $HIMS....and size always matters, for sure and we can make a lot of $$$, by not getting carried-away....Good Luck!
  • oldmaratom: @champ $HIMS # is that what you meant? Thank You for all You do .
  • stairm01: $HIMS Wow! I bought 500 shares of HIMS yesterday on a break above the 21 ema and high volume. Wish I would've bought more. Up $10 premarket. Can't find any news.
  • kenb: @stairm01 $HIMS nice. "Health and wellness company, which sells alternatives to weight-loss drugs like Wegovy, is now collaborating with the Wegovy maker Shares of Hims & Hers Health Inc. were headed for their best day ever early Tuesday trading, after the health and wellness company basically teamed up with its competition, the maker of the weight-loss drug Wegovy."
  • cgendro1: @stairm01 $HIMS Article on CNBC- Novo Nordisk offering Wegovy through telehealth providers: Him &Hers, RO and Life MD
  • stairm01: @kenb $HIMS Thanks!
  • stairm01: @cgendro1 $HIMS Thanks!
  • camaro69: @stairm01 $HIMS Home run! Yea!
  • curtis: @stairm01 $HIMS (They sell Boner Pills...hair loss. GLP1, without having to go to a Dr in person and ask for them.) Good business model.
  • vitoB: Im anticipating this be day 3 of some selling and they at least take a breath. Lookin at some beaten down tickers as 59ers $META $AMZN of the big guns. $NOW $TTD $ANF $DECK $HIMS all broken uglies but lookin at potential dtrade b 59ers…. Lookin for positive reactions at vwap and any big green volume bars on the two min chart.
  • vitoB: @vitoB $META $AMZN $NOW $TTD $ANF $DECK $HIMS ….. hims and ttd worked should be out
  • woodman: $HIMS - party may over for obesity drug compounders (though HIMS compounds drugs other than obesity drugs) with FDA's official announcement $NVO's Ozempic/Wegovy shortages (like $LLY's Zepbound/Mounjaro) are over, though I have a friend who said CVS told him there was some kind of problem filling his Zepbound prescription due to lack of supply, which is odd.
  • RichardinME: $HIMS Possibly 59 minute trade? Maybe too late as it was down to 49 earlier?
  • joelsg1: $HIMS Losing weight as FDA lifts supply constraints on $NVO and $LLY weight loss drugs, Death knell for copycat compounders IMO. Might short any bounce.
  • marklesparkle: @joelsg1 $HIMS $NVO $LLY Joel now that has a ring to it death knell for copycat compounders
  • joelsg1: @marklesparkle $HIMS $NVO $LLY New punk band?
  • woodman: @joelsg1 $HIMS $NVO $LLY - Good call.
  • Dig44north: @joelsg1 $HIMS $NVO $LLY $LLY is strong, climbing the upper bb on the 5 min chart. Looking to take out my 900 cc
  • joelsg1: $HIMS Closed a $6 small short.
  • woodman: @DavidG $VKTX - Lots of theories, because, you know, there's always a reason for a move, right? I don't know anything specifically attributed to this move that I'd call reliable. I saw some references to VK2735 and VK0214 trial recruitments/starts/co ...
  • woodman: @woodman $VKTX $ALT $LLY $GPCR $HIMS $NVO - Just saw this. Cowen GLP-1 Market: The Pipeline Expands - Global GLP-1 sales in 2030 could reach $139B, up from our $101B forecast a little over a year ago. The market is maturing but accruing health outcomes data should broaden access and maintain momentum.
  • woodman: @woodman $VKTX $ALT $LLY $GPCR $HIMS $NVO - Interesting that VKTX has dropped to a $3.8B market cap, and ended 2024 with a decent cash position of $903 million. But it is running multiple trials now, so it will have to burn a lot.
  • Mikev200: $HIMS wooowza
  • Mikev200: $HIMS another lil boom
  • woodman: @Mikev200 $HIMS - in anticipation of Super Bowl ads?
  • Henry: $HIMS is this the price action you get with a Super Bowl ad? np
  • scottrades: $HIMS Working well here but extended now.
  • woodman: @scottrades $HIMS - in anticipation of it have ads during the Super Bowl? (Fly Eagles Fly!)
  • Mikev200: $HIMS holding strong
  • sridhar721: $HIMS $HIMS breaking out
  • woodman: $HIMS has had a nice recovery, now about a buck from its ath. I heard it bought its first ever super bowl commercial spot.
  • debeers: @woodman $HIMS - it did! good for you Woody!
  • woodman: @debeers $HIMS - I don't have it. Just noticed the chart.
  • camaro69: @kohli1 $HIMS working nice!
  • camaro69: $HIMS up 12% HOD on news
  • kohli1: $HIMS - I bt some this morning for initial thought of daytrade with a plan to close near 22. Is it a good idea to keep some for swing? If so, I like to get some ideas on that.
  • bob212: @kohli1 $HIMS
  • Bridgemate: $HIMS joining S&P 600 on Oct 9
  • Henry: $HIMS Gotlieb said the GLP-1's are off the shortage list and the FDA ought to be cracking down on the compounding pharmacies.
  • Obsxllc: @Henry $HIMS the 503B sterile labs are on "fire" with the production of GLP-1s and most independent pharmacies in most states can access these items for CASH sells. On the other hand the 503A NON sterile labs is where the FDA needs to use their resources in my view
  • woodman: @Henry $HIMS - is much more than an obesity medication/treatment company. That said, obesity treatment is also a large - and growing - part. Here's a good article. The company believes there is plenty of money to be made still in the obesity TA. https://www.fiercehealthcare.com/health-tech/hims-hers-projects-2024-revenue-hit-137b-buoyed-demand-weight-loss-drugs Also, this one discusses the company's moving into the more untapped area of women's health (vs. men's health). https://www.axios.com/2024/08/08/hims-hers-womens-health-weight-loss
  • woodman: @Henry $HIMS - I posted this below in reply, but re-posting up higher since you may not see it: $HIMS is much more than an obesity medication/treatment company. That said, obesity treatment is also a large - and growing - part. Here's a good article. The company believes there is plenty of money to be made still in the obesity TA. https://www.fiercehealthcare.com/health-tech/hims-hers-projects-2024-revenue-hit-137b-buoyed-demand-weight-loss-drugs Also, this one discusses the company's moving into the more untapped area of women's health (vs. men's health). https://www.axios.com/2024/08/08/hims-hers-womens-health-weight-loss
  • woodman: $HIMS may well end up having a good day today. Initially, it was down a lot after it reported yesterday. Now down only about 1% here in the pre. It beat the consensus (though not Earnings Whisper) on revs, earnings and it guided higher.

    Hims & H ...
  • woodman: @woodman $HIMS - my theory not looking so good.... I'm staying in my foxhole.
  • woodman: $HIMS - nice comeback today. It reports amc. I think it will beat, but guidance will be curious given some news about obesity drug shortages being over. However, many don't think much about HIMS being much more than obesity meds. I was going to play the earnings casino game, but not in this enviroment. I'm not risking overnight Middle East news this week.
  • woodman: $HIMS collapsed around 12:45.
  • woodman: $HIMS - Last 2 Qs have led to big moves the day after reporting. I plan to hold a position through earnings (size of position to be determined still). It reports 8/5 amc.
  • woodman: $HIMS - last two earnings were blowouts, up nearly 35% the next day each time. Earnings are 8/5 amc.
  • joelsg1: @woodman $HIMS But all I see is Blue Chew...
  • traderbren: @joelsg1 $HIMS - LOL...good one! ;-)
  • joelsg1: $HIMS Apparently the FDA warned against non-approved GLP-1 drugs a few hours ago. https://www.usnews.com/news/us/articles/2024-07-26/us-fda-warns-of-dosing-errors-with-compounded-versions-of-novos-weight-loss-drugs
  • woodman: $HIMS has been consolidating. The rising 50d has caught up. Still an inside day.
  • woodman: $HIMS nice pop this morning.
  • Motorman: @woodman $HIMS Hey Doc, for got to ask. Are you a Nephrologist?
  • woodman: @Motorman $HIMS - Me? I'm not a physican. I only play one on TV. Other than by way of lay person "study" (reading a lot), my limited personal experience with nephology comes as a result of having a kindey removed following discovery of renal cancer and seeing a nephrologist once a year in follow-up. I've mentioned before that I'm not a doctor or even practiced in the sciences. I just study what I can. But I don't want there to be any confusion about that.
  • joelsg1: @woodman $HIMS Juris "Doctor" counts :)
  • woodman: @joelsg1 $HIMS - Thank you. I will quote you to the Medical Board. :-0
  • joelsg1: @woodman $HIMS "Florida Medical Board", "Dr. Hackenbush" :)
  • woodman: @joelsg1 $HIMS - Ha! I was going with "Dr. Beeper."
  • Henry: $HIMS Got hit by a short report from Hunterbrook
  • ZMan2: @Henry $HIMS Thanks or the info. I could find a reason for the 10%2B% drop in the pre-market.
  • ZMan2: $HIMS 10%2B % drop in the pre market.
  • woodman: $HIMS trying to find support at the 21dEMA.
Visit the Trading Forum to join in the discussion.
Stock Price $44.57
Change 1.39%
Volume 27,941,900

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Request Video of HIMS
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!